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ABSTRACT 
 
A study of the evolution of health care systems in Canada and Europe shows that the earlier effort 
at making health care services available to everybody was followed by reform measures focused 
on cost containment. In the U.S., the rapid rise in health care cost and low access are widely 
recognized as twin problems. Health care reform in this country first focused on cost containment 
through managed care to make health insurance affordable, and then shifted to expanding access 
to coverage at the state level without doing away with the private health insurance market.  
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INTRODUCTION 
 
he United States remains the only high-income member of the Organization for Economic 
Cooperation and Development (OECD) that does not have universal health care coverage. The health 
care system is predominantly private in both financing and delivery.  Most health care services are 
delivered by private providers, and over half are funded by private insurance and/or paid for by the patient out-of-
pocket. Public programs such as Medicare for the elderly and disabled, Medicaid for non-elderly, low-income 
individuals and their dependents, and the State Children‟s Health Insurance Program (SCHIP) for low-income 
children serve as multiple payers for benefit packages purchased from private health insurers (Gruber 2008). Both 
Medicaid and SCHIP are funded by state revenues with federal matching grants, while Medicare is financed through 
a trust fund funded by payroll taxes. The absence of mandatory purchase of health insurance has led to adverse 
selection characteristic of voluntary insurance markets.  The ability of insurance to pool financial risk and promote 
access to services is weakened because those with greater health risks are more likely to take out insurance and to 
insure at higher levels, as compared with those in good health. Profit-motivated, private health insurers are likely to 
raise health care premiums to keep up with rising reimbursements. Self-interest based on rational cost-benefit 
analysis causes healthier individuals to opt out of health insurance, thus increasing the risk among the pool of 
insured. This leads to a never-ending cycle of increasing reimbursement, premium, and risk pool that can eventually 
lower coverage to those who are insured, or worse, limit access to affordable insurance for higher-risk individuals.  
 
According to OECD Health Data (2006), the U.S. has the highest per capita health care expenditure 
($5,711) – more than twice the OECD average of $2,818. It also shows the U.S. share of health care in GDP (15.3%) 
as the highest, with the OECD average only at 9%. Data compiled for Academy Health (2007) by University of 
Minnesota‟s School of Public Health show that between 2001 and 2006, the increase in health insurance premiums 
(78%) exceeded wage growth (19%), and overall inflation (17%).  The rising cost of health insurance has led 
initially to an increase in lower-cost benefit plans that cover fewer services and/or have higher patient cost share, 
and recently to a decline in employer sponsored-health coverage. As a result, the number of uninsured has risen to 
47 million or 16% of the population as of 2007(Academy Health 2008).   
 
T 
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Several economic principles explain why the cost of health care may rise faster than other goods and 
services.  The availability of third-party insurance poses a moral hazard of overconsumption on the part of some 
patients. Further increasing demand is information asymmetry between patient and physicians, along with the risk of 
malpractice lawsuits, which can lead to unnecessary services being prescribed. Among the uninsured, demand 
elasticity suggests that the price increase brought about by excess demand can reduce consumption of preventive 
care and health services for non-life threatening illnesses.  Reduced utilization by those who cannot afford to buy 
insurance on their own could mean higher health care costs for the country in the long-run.  
 
Canada, the United Kingdom, and other high-income OECD members in Europe provide universal 
coverage. Their systems rely heavily on public financing through a combination of a social security trust fund and 
general tax revenues. In Canada, Japan, Germany, and France health care delivery by private health care agencies is 
combined with public financing (Cutler 2002).  In the so-called public integrated system of the U.K., Norway, 
Sweden, Finland, Greece, Portugal, Spain and New Zealand, insurance and service delivery are handled by a single 
public agency (Docteur and Oxley 2003).  During the 1960s and 1970s, many countries with universal coverage 
found that health-care spending grew at rates that most governments considered unsustainable with public finances. 
With various cost containment measures, spending growth has slowed considerably over the past two decades, but 
continues to grow at rates exceeding overall economic growth in many OECD countries. According to OECD 
Health Data (2006) over the period 1960-2004, the share of health care expenditures in GDP among high income 
OECD countries rose by an average of 5% per year. Only the rates for the U.S. (6.2%) and France (5.7%) exceeded 
this average. In 2002-2003, health care expenditures in OECD countries grew at an average of 4.8%. The countries 
that experienced above average growth rates for health care expenditures, in descending order, are Luxembourg, 
Belgium, Hungary, Spain, the Czech Republic, Iceland, Korea, Turkey, Greece, and the U.S. 
 
FOCUS ON COST CONTAINMENT IN CANADA AND EUROPE 
 
The designs of health care systems in OECD countries with universal coverage vary in terms of how cost-
containment is achieved. The system that is most likely to restrain health care expenditure growth through 
contractual cost savings and internal coordination and administrative simplicity is the public integrated system.  An 
agency at the local or central government level controls funding and provision of care (Cutler 2002). Doctors are 
salaried and public hospitals are funded through a block grant.  However, the absence of competition and choice 
under this system is more likely to compromise quality of care and patient satisfaction.  Okunade et al. (2004) 
classified countries that combine public financing of health care with private delivery into those that employ the 
public reimbursement method (Australia, Belgium, France, Japan, Luxembourg, and Switzerland), and those that use  
the contract method (Denmark, Iceland, Ireland, the Netherlands).  Under the public reimbursement method, 
providers are paid retrospectively (or after providing services to patients) by the public insurance fund, or by the 
patients who are later reimbursed in part or in full by the public insurance fund. The payments are considered more 
liberal, thus making cost control incentives under this system fairly weak.  The contract system grants third party 
payers greater control over health expenditure budgets and their distribution than the reimbursement method. Public 
insurance agencies enter into a prospective agreement with primary care physicians who receive per diem caps for 
each registered patient. Hospitals are funded on a per diem or case mix basis.  
 
Following the progress made by the U.S. in cost containment through managed care, Canada, the U.K. and 
other OECD countries in Europe adopted different measures beginning in the mid-1990s.  Most of these measures 
were aimed at containing health care costs, but in some cases, increasing patient choice as well. The following 
summary of reform measures is based on an OECD-funded study by Docteur and Oxley (2003): 
 
1. Cost-shifting (public to private) on the financing side 
 
 increasing out-of-pocket payments through user fees, reimbursement caps, deductibles, or co-insurance  
 reducing services covered by public insurance  
 annual ceiling on national health care spending  
 increasing co-pay for branded drugs by reimbursing patients only up to the cost of lowest priced, or generic 
drugs 
International Business & Economics Research Journal – October 2008 Volume 7, Number 10 
17 
 allowing use of private complementary insurance to cover cost-share, and supplemental insurance to reduce 
waiting time or increase patient choice 
 
2. Cost shifting on the delivery side 
 
 contracting out ambulatory care to private practitioners to reduce demand for higher cost inpatient care  
 
3. Increased use of ambulatory care gatekeepers and capitated payments   
 
 paying primary care physicians (PCPs) a fixed amount per registered patient, depending on age or gender, 
as an incentive to find cost-effective treatments  
 requiring PCP referral to see a specialist to reduce demand for more expensive specialty care  
 coordinating PCP and specialist care to reduce cost and improve treatment outcomes. 
 
4. Reimbursements using diagnosis-related group (DRG) payment schedules  
 
 restraining providers from prescribing unnecessary services and over-pricing.  
 
5. Increasing competition  
 
 among insurers by allowing patients to shop for the most desirable cost-coverage mix 
 among PCPs by allowing patients expanded choice or providers 
 among hospitals for elective surgery to cut waiting times  
 among ambulatory care providers by allowing autonomous purchasing authorities to enter into contracts 
with providers specifying volume caps and quality specifications. 
 
In the case of prescription drugs, dental care and hospitalization, the average insured American probably 
has a lower out-of-pocket cost.  According to a study by Scheil-Adlung (1998), a patient‟s share of drug costs varies 
widely across countries with universal coverage. Some were proportional (10-25% in Greece, 20% in the 
Netherlands, 25-50% in Denmark, and 35-65% in France), and others were a fixed amount per prescription ($5 in 
Austria and Italy, $9-$13 in Germany, $8-$48 in Australia). Quarterly deductibles equal to $57 were used       in the 
U.K. and $211in Ireland. In most cases, exemptions or reductions were granted to those who had chronic illnesses, 
and to vulnerable groups (the poor, unemployed or elderly).  The cost of dental services borne by patients were 
usually proportional (20% in the U.K., 25% in Belgium, 30% in France, 25-50% in Austria, 55-60% in Denmark, 
30-75% in Sweden, and 100% in Canada), but in the case of Australia a fixed deductible of $118. Patient‟s co-pay 
for the costs of hospitalization and hospital supplies were used by Austria, Belgium, Germany, Ireland, and Sweden 
in the range of $9 to $16 per day. Austria capped the number of covered hospitalization to 28 days per year. In many 
countries, eye care and prescription glasses are not covered by public insurance. 
 
 Due to a longer experience with managed care, the U.S. is a step ahead of Canada and European countries 
in controlling the resulting cost-quality tradeoff. After two versions of a patient‟s bill of rights stalled in Congress in 
2002, the Supreme Court upheld a patient‟s right to sue Health Management Organizations (HMOs) in state courts 
for alleged adverse effects on quality of care, and in some cases, death, arising from denial of coverage (Holt 2002).  
 
FOCUS ON EXPANDED ACCESS IN THE U.S. 
 
To put it simply, the uninsured in the U.S. consist of working adults who are not poor enough to qualify for 
Medicaid, too young for Medicare, and too old for SCHIP. According to a study of health initiatives by states 
funded by the R.W. Foundation (Academy Health, 2007) almost half of Hispanic and Native Americans, and about a 
fifth of non-elderly rural residents are uninsured. The number of uninsured Americans would have been much higher 
without Federal legislation that required states to increase the eligibility income cut-off for Medicaid from 25% 
below FPL to 33% above it between 1988 and 1993. Due to a consensus in Congress that access by low-income 
women to prenatal care would reduce the incidence of low birth weight and hence, infant mortality, the Federal 
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government provided matching funds to states that extended Medicaid eligibility to pregnant women with incomes 
up to 185% FP (Fergusson 1999).  As a result, World Bank development statistics show that between 1960 and 1998 
the public share of national health expenditures in the U.S. increased five times, while the private share less than 
doubled. In 1960, public health expenditure was 1.2% of GDP in the U.S., just about half of the OECD average 
(World Bank, 2007). This gap was closed in 1998, with U.S. public spending on health care rising to 6.1% of GDP, 
just above the OECD average was at 6%.  
 
 We can expect the public share of total health expenditures in the U.S. to exceed the private share soon 
because of the following developments:  
 
1) Addition of a prescription drug program to Medicare in 2006 (Hoadley et al. 2006),  
2) Programs targeting universal coverage initiated between 2003 and 2006 by Maine, Vermont, and 
Massachusetts (Academy Health 2007), and  
3) Ongoing efforts at expanding access to targeted groups (children, employees of small businesses, near poor 
working families) by at least 12 other states (McDonough et al. 2008, Academy Health, 2008). 
 
Maine‟s Dirigo Health Reform Act of 2003 aims at universal coverage by 2009 through voluntary 
insurance purchase, targeting small businesses, the self-employed and individuals without access to employer-
sponsored insurance and whose incomes are below 300% of the federal poverty level (FPL). Maine entered into an 
exclusive contract with the largest private insurance company to offer affordable plans with a sliding scale of 
discounted premiums, reductions in deductibles, and caps on out-of-pocket expenses depending on income.  
 
Massachusetts Commonwealth Care was enacted in 2006, aiming at covering 95% of the uninsured in three 
years by mandating individuals and employers with 11 or more employees to purchase one of three affordable 
benefit packages. State general revenues and federal matching grants for Medicaid will pay for free coverage to 
those with incomes below FPL, and subsidize employer and individual premiums. Beginning July 1, 2007, an 
eligible individual who does not purchase coverage will lose the personal exemption from income taxes that year, 
and pay a fine equal to half of the monthly cost of insurance for each month without coverage. For employers, the 
penalty is a share of health care cost in excess of $50,000 that is billed to the state whenever uninsured full-time 
employees or their dependents access free care from hospitals and other providers.  
 
 Vermont‟s Catamount Health Plan was implemented in October 2007 and aims at universal coverage by 
2010. The state offers a new insurance product with subsidies for individuals below 300% FPL. Employers are 
mandated to provide coverage to their employees and penalties are assessed on those who do not. Funding comes 
from increased tobacco tax, federal matching grants for Medicaid, and subsidized premiums paid by enrollees. The 
state also offers chronic disease management for the Medicaid population. 
 
Illinois, Pennsylvania, New York, Tennessee, Wisconsin, and Washington have begun working towards 
covering all children including those of families with incomes above the SCHIP eligibility level.  States that are 
working towards expanded access for low-income adults and/or small businesses include Arkansas, Minnesota, New 
Mexico, Oklahoma, Oregon, Rhode Island, Tennessee, Utah, Montana, Pennsylvania, South Dakota, and West 
Virginia (Academy Health, 2008). 
 
Three states unveiled plans for universal coverage in 2007: California, Pennsylvania and New Mexico 
(Academy Health 2008).  However, Gov. Schwarzenegger‟s proposal failed to pass the California legislature last 
year.  Under his “Prescription for Pennsylvania” plan, Gov. Rendell is continuing to develop a comprehensive single 
payer health care reform proposal that would achieve universal coverage, along with health systems improvements 
and rewards individuals for healthy behavior. Another proposal for universal coverage was unveiled in 2007 by New 
Mexico Gov. Richardson. 
 
In the 2008 Presidential election, universal health coverage at the national level is on each primary 
candidate‟s   agenda.  While similar in containing goals for improving health care quality, containing costs, and 
subsidizing premiums for low income individuals and families, a major difference between the two is mandatory 
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purchase under the Clinton Plan (Clinton 2007), and voluntary purchase under the Obama Plan (Obama 2007). The 
Clinton Plan is viewed to be superior because it addresses the adverse selection problem inherent in voluntary 
insurance, but Obama‟s ability to rally grassroots support to counteract countervailing forces from the drug industry 
and fiscal conservatives in Congress, probably gives him an edge in terms of actually getting a legislation passed. 
With the country still at war, and the economy‟s weakness contributing to the rising public debt, the passage of any 
universal health care legislation ultimately hinges on whether the Bush tax cut for the highest income Americans can 
be reversed as both Clinton and Obama intend to fund their plans with the resulting tax revenues. The more likely 
scenario is that the U.S. will continue treading on an incremental path to universal coverage with a mix of initiatives 
at the state and federal levels. One possibility will be the use of block grants from the federal government as in the 
post 1996 welfare program. This would make states „laboratories‟ for different health plans, while at the same time 
equalizing their disparate revenue bases.  
 
CONCLUSION 
 
 From the above discussion, it may be concluded that the health care systems of the U.S. and OECD 
countries with universal coverage are in the process of convergence, spurred by the challenging problem of 
providing high quality, but affordable, health care to all people.  The design of health care systems in Canada and 
Europe now exhibit a trend towards the use of supplemental private insurance, reduced public coverage or increased 
patient‟s cost share, decentralization or reduced government control of health care delivery, the use of gatekeepers, 
DRG reimbursements, and other managed care practices that became widely used in the U.S. since the 1980s.  At 
the same time, public expenditures for health care in the U.S. are expected to exceed private expenditures in the near 
future, mainly because of the Federal government‟s prescription drug program for the elderly, universal coverage 
programs implemented by three states, and many other state initiatives to expand access to health insurance through 
existing public programs as well as by subsidizing the purchase of coverage from private health insurers. It is likely 
that the U.S. will keep its predominantly private health insurance market, but it is not clear whether and when 
universal coverage at the national level through a federal mandate to purchase health insurance will become a 
reality. 
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